NVO
Novo Nordisk A/S
NYSE: NVO · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$42.22
+4.79% today
Updated 2026-04-30
Market cap
$182.60B
P/E ratio
11.40
P/S ratio
0.59x
EPS (TTM)
$3.61
Dividend yield
4.38%
52W range
$35 – $78
Volume
21.0M
Novo Nordisk A/S (NVO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $44.70B | $47.80B | $50.73B | $54.74B | $61.40B | $64.70B | $65.67B | $70.34B | $77.06B | $91.80B | $97.54B | $102.36B | $110.77B | $18.87B | $23.82B | $194.51B | $241.26B | $314.49B | $465.80B | $542.90B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $20.84B | $24.33B | $29.14B | $32.67B | $37.29B | $39.59B | $40.16B | $42.06B | $46.29B | $55.14B | $59.77B | $60.08B | $59.07B | $9.38B | $10.82B | $85.59B | $108.19B | $139.65B | $160.90B | $172.45B |
| Total liabilities | $14.57B | $15.57B | $17.67B | $19.01B | $24.44B | $27.25B | $25.04B | $27.77B | $36.77B | $44.83B | $52.27B | $52.54B | $58.93B | $10.22B | $13.41B | $123.76B | $157.77B | $207.93B | $322.31B | $348.86B |
| Current liabilities | $10.16B | $10.66B | $12.99B | $13.41B | $18.48B | $20.78B | $21.64B | $24.23B | $33.69B | $40.87B | $47.44B | $47.06B | $54.16B | $8.86B | $11.55B | $99.52B | $120.94B | $169.66B | $217.53B | $215.66B |
| Long-term debt | $207.87M | $188.26M | $183.19M | $186.87M | $89.71M | $87.60M | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $9.65B | $20.77B | $15.98B | $84.25B | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $28.81B | $30.70B | $33.51B | $35.15B | $36.10B | $37.11B | $39.00B | $41.14B | $41.28B | $46.82B | $46.11B | $48.98B | $53.41B | $8.69B | $10.48B | $72.00B | $80.59B | $104.84B | $144.45B | $195.30B |
| Accounts receivable | $6.50B | $7.31B | $8.72B | $9.13B | $10.94B | $11.67B | $12.55B | $11.61B | $15.79B | $17.74B | $24.20B | $23.55B | $26.89B | $3.86B | $4.61B | $46.80B | $57.51B | $75.26B | $87.41B | $75.70B |
| Inventory | $8.40B | $9.03B | $9.63B | $10.02B | $9.69B | $9.43B | $9.54B | $9.55B | $11.36B | $12.76B | $14.34B | $15.37B | $16.34B | $2.65B | $3.05B | $19.62B | $24.39B | $31.81B | $40.85B | $49.62B |
| Goodwill | $16.95M | $66.48M | $13.27M | $14.26M | $70.00M | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.35B | $5.09B | $4.46B | $20.06B | $19.84B |